Best treatments for polycythemia vera
8 products may treat polycythemia vera, spanning FDA drug classes such as platelet-reducing agent, alkylating drug, janus kinase inhibitor. The current highest-rated option is anagrelide hydrochloride. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 8 drugs we list for polycythemia vera, 2 are available as lower-cost generics, spanning classes such as platelet-reducing agent, alkylating drug, janus kinase inhibitor. 1 of 8 carry a safety score of 72 out of 100. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for polycythemia vera — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Capsule | Platelet-reducing Agent | Generic | $32 | View → | |
| 2 | Not yet rated | Prescription | Capsule | Platelet-reducing Agent | Generic | $32 | View → | |
| 3 | Not yet rated | Prescription | Injectable | — | No data | — | View → | |
| 4 | Not yet rated | Prescription | Injectable | Alkylating Drug | No data | — | View → | |
| 5 | Not yet rated | Prescription | Tablet | Janus Kinase Inhibitor | No data | — | View → | |
| 6 | Not yet rated | Prescription | Tablet | Janus Kinase Inhibitor | No data | — | View → | |
| 7 | Not yet rated | Prescription | Tablet | Alkylating Drug | No data | — | View → | |
| 8 | Not yet rated | Prescription | Topical | Janus Kinase Inhibitor | No data | — | View → |
Narrow by drug class
Explore the class hubs: janus kinase inhibitor · alkylating drug · platelet-reducing agent
Full ranking · 8 treatments
anagrelide hydrochloride
PrescriptionFDA-sourced
Anagrelide Hydrochloride is a platelet-reducing agent used to treat Polycythemia Vera, Thrombocytosis.
Pharmacy pays
From ~$21.88/30· 2 forms
agrylin
PrescriptionFDA-sourced
Agrylin (Anagrelide Hydrochloride) is a platelet-reducing agent used to treat Polycythemia Vera, Thrombocytosis.
Pharmacy pays
From ~$21.88/30· 2 formsbesremi
Boxed warningPrescriptionFDA-sourced
Besremi (Ropeginterferon Alfa-2b-Njft) is a medication used to treat Polycythemia Vera.
Price varies
busulfex
PrescriptionFDA-sourced
Busulfex (Busulfan) is an alkylating drug used to treat Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis.
Price varies
jakafi
PrescriptionFDA-sourced
Jakafi (Ruxolitinib Phosphate) is a janus kinase inhibitor used to treat Polycythemia Vera, Primary Myelofibrosis.
Price varies
jakafi xr
PrescriptionFDA-sourced
Jakafi XR (Ruxolitinib Phosphate) is a janus kinase inhibitor used to treat Polycythemia Vera, Primary Myelofibrosis.
Price varies
Frequently asked
- What treats polycythemia vera?
- Our catalog lists 8 products that may treat polycythemia vera, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is anagrelide hydrochloride.
- What is the best-rated treatment for polycythemia vera?
- By our independent recall-safety rating — not an efficacy measure — anagrelide hydrochloride ranks highest among the products we list for polycythemia vera. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat polycythemia vera?
- Treatments for polycythemia vera span FDA drug classes including platelet-reducing agent, alkylating drug, janus kinase inhibitor, kinase inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status